Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigrid Carlsson

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Urology|December 19, 2015
The Effect of Start and Stop Age at Screening on the Risk of Being Diagnosed with Prostate CancerRebecka Arnsrud Godtman, Sigrid Carlsson, Erik Holmberg, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Comparison of Physician-Documented Versus Patient-Reported Collection of Comorbidities Among Patients With Prostate Cancer Upon First Visit to the Urology ClinicKatherine Fleshner, Amy Tin, Nicole Benfante, et al.
Dysphagia|November 23, 2011
Validation of the Swedish M. D. Anderson Dysphagia Inventory (MDADI) in patients with head and neck cancer and neurologic swallowing disturbancesSigrid Carlsson, Anna Rydén, Ingrid Rudberg, et al.
Lancet (London, England)|May 2, 2015
Prostate cancer screening in Europe - Authors' replyFritz Schröder, Jonas Hugosson, Sigrid Carlsson, et al.
Journal of the National Cancer Institute|April 29, 2014
RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connectionSigrid Carlsson, Monique J Roobol, Fritz H Schröder, et al.
Cardiovascular Diabetology|December 24, 2025
Improved sex-specific cardiovascular risk prediction with multi-omics data in people with type 2 diabetesRuijie Xie, Christian Herder, Sha Sha, et al.
European Urology Focus|August 15, 2017
Impact of Prostatic-specific Antigen Threshold and Screening Interval in Prostate Cancer Screening Outcomes: Comparing the Swedish and Finnish European Randomised Study of Screening for Prostate Cancer CentresLasse Saarimäki, Jonas Hugosson, Teuvo L Tammela, et al.
Journal of the National Cancer Institute|March 11, 2014
Prostate cancer mortality in areas with high and low prostate cancer incidencePär Stattin, Sigrid Carlsson, Benny Holmström, et al.
Cancer Causes & Control : CCC|December 26, 2012
Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based studyStacy Loeb, Linda Drevin, David Robinson, et al.
European Urology|April 17, 2016
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort StudySigrid Carlsson, Melissa Assel, David Ulmert, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Urology|December 19, 2015
The Effect of Start and Stop Age at Screening on the Risk of Being Diagnosed with Prostate CancerRebecka Arnsrud Godtman, Sigrid Carlsson, Erik Holmberg, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Comparison of Physician-Documented Versus Patient-Reported Collection of Comorbidities Among Patients With Prostate Cancer Upon First Visit to the Urology ClinicKatherine Fleshner, Amy Tin, Nicole Benfante, et al.
Dysphagia|November 23, 2011
Validation of the Swedish M. D. Anderson Dysphagia Inventory (MDADI) in patients with head and neck cancer and neurologic swallowing disturbancesSigrid Carlsson, Anna Rydén, Ingrid Rudberg, et al.
Lancet (London, England)|May 2, 2015
Prostate cancer screening in Europe - Authors' replyFritz Schröder, Jonas Hugosson, Sigrid Carlsson, et al.
Journal of the National Cancer Institute|April 29, 2014
RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connectionSigrid Carlsson, Monique J Roobol, Fritz H Schröder, et al.
Cardiovascular Diabetology|December 24, 2025
Improved sex-specific cardiovascular risk prediction with multi-omics data in people with type 2 diabetesRuijie Xie, Christian Herder, Sha Sha, et al.
European Urology Focus|August 15, 2017
Impact of Prostatic-specific Antigen Threshold and Screening Interval in Prostate Cancer Screening Outcomes: Comparing the Swedish and Finnish European Randomised Study of Screening for Prostate Cancer CentresLasse Saarimäki, Jonas Hugosson, Teuvo L Tammela, et al.
Journal of the National Cancer Institute|March 11, 2014
Prostate cancer mortality in areas with high and low prostate cancer incidencePär Stattin, Sigrid Carlsson, Benny Holmström, et al.
Cancer Causes & Control : CCC|December 26, 2012
Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based studyStacy Loeb, Linda Drevin, David Robinson, et al.
European Urology|April 17, 2016
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort StudySigrid Carlsson, Melissa Assel, David Ulmert, et al.
Pageof 10